EdiTy Therapeutics
Rehovot · Founded 2020
About EdiTy Therapeutics
EdiTy Therapeutics is a biotechnology company that develops a gene-editing technology designed for in-vivo gene-editing of target cells. It utilizes T-cells machinery to directly deliver gene-editing agents to target cells in-vivo. Michal Golan Mashiach established the Rehovot, HaMerkaz, Israel-based company in 2020.
Company Facts
- Founded: 2020
- Legal name: Edity Therapeutics Limited
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Funding stage: Seed
- Last round: Seed (Jul 2022)
- Website: edity-tx.com
Social Profiles
Canonical: https://fsome.com/organization/edity-therapeutics-8403860 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.